INTRODUCTION
============

The coordinated action of the nuclear exosome and its cofactor Trf4/5p-Air1/2p-Mtr4p polyadenylation (TRAMP) complex contributes substantially to the rapid degradation of unwanted RNA transcripts in the nucleus ([@gkt888-B1]). A great variety of different RNA substrates, such as cryptic unstable transcripts (CUTs), abnormally processed snRNAs, snoRNAs and rRNAs, hypomodified tRNAs, defective ribonucleoproteins (RNPs) and non-coding RNAs, are degraded via this nuclear RNA quality control pathway ([@gkt888-B5]). In the current model ([@gkt888-B3]), most RNA transcripts that should be degraded by the nuclear exosome are first recognized by TRAMP through its RNA-binding subunit Air1p or Air2p ([@gkt888-B18]), which regulates the substrate recognition specificity of TRAMP ([@gkt888-B21]). After that, a short poly(A) tail is added to the 3′ end of the TRAMP-bound RNA transcripts by its non-canonical poly(A) polymerase subunit Trf4p or Trf5p ([@gkt888-B3]), with poly(A) tail length being controlled by its ATP-dependent 3′--5′ RNA helicase subunit Mtr4p ([@gkt888-B22]). This poly(A) tail serves as the docking site for the nuclear exosome, which then binds to and finally degrades the RNA transcripts using its endoribonucleolytic ([@gkt888-B23],[@gkt888-B24]) and 3′ to 5′ exoribonucleolytic activity ([@gkt888-B1],[@gkt888-B2],[@gkt888-B6]) with the help from the RNA unwinding activity of Mtr4p ([@gkt888-B25]). Cotranscriptional recruitment of TRAMP to a CUT ([@gkt888-B26]) and several snoRNA genes ([@gkt888-B27]), and that of the nuclear exosome to nascent transcripts synthesized by RNA polymerase II ([@gkt888-B28]), has been previously described. These suggested the possibility that many unwanted RNA transcripts may already be bound by these nuclear RNA quality control factors during transcription.

Pre-mRNA splicing ([@gkt888-B31]) is a relatively error-prone process which possibly leads to the production of splicing-defective pre-mRNAs, and must inevitably synthesize spliced-out introns as normal splicing by-products. Both splicing-defective pre-mRNAs and spliced-out introns are probably harmful to cells. While splicing-defective pre-mRNAs may be exported into cytoplasm and then translated into potentially deleterious proteins ([@gkt888-B32]), the accumulation of spliced-out introns may lead to a severe growth defect, at least in fission yeast ([@gkt888-B35]). To minimize their potentially harmful accumulation, splicing-defective pre-mRNAs are rapidly degraded in the nucleus by the nuclear exosome ([@gkt888-B36]) and/or after export into the cytoplasm by both non-sense mediated decay (NMD) ([@gkt888-B37],[@gkt888-B38]) as well as NMD-independent pathways ([@gkt888-B39]). Likewise, effective RNA degradation systems should also exist for the removal of spliced-out introns, which are likely generated before transcription termination as splicing occurs cotranscriptionally ([@gkt888-B40]). A previous RNA-IP-chip analysis demonstrated that Trf4p can bind to spliced-out introns ([@gkt888-B45]). More recently, the physical interaction between U4/U6-U5 tri-small-nuclear-ribonucleoproteins (tri-snRNPs) splicing factors with TRAMP and nuclear exosome components has also been observed in mammalian cells ([@gkt888-B46]). These findings implied that spliced-out introns are recognized by TRAMP before subsequent degradation by the nuclear exosome. However, it remains unclear whether intronic sequences are also bound by TRAMP in a cotranscriptional manner, and how the cotranscriptional recruitment of TRAMP (if any) is functionally linked to pre-mRNA splicing.

In this study, we found that TRAMP, together with the nuclear exosome component Rrp6p, is cotranscriptionally recruited to nascent transcripts synthesized from both an artificial intron-containing *lacZ* reporter construct ([@gkt888-B32]) and a number of endogenous intron-containing genes, with significant enrichment at the intronic sequences. We infer that the cotranscriptional recruitment of TRAMP and Rrp6p to intronic sequences may serve an important role in committing the spliced-out introns, and very likely also the splicing-defective pre-mRNAs generated due to splicing errors, to nuclear-exosome-mediated degradation. Interestingly, we found that the cotranscriptional recruitment of TRAMP to intronic sequences (but not that of Rrp6p) has an additional function to facilitate pre-mRNA splicing. This novel finding is further supported by the genetic and physical interactions between the TRAMP component Trf4p and several splicing factors. We also showed that Trf4p can enhance the recruitment of Msl5p (one of the splicing factors that showed physical interaction with Trf4p) to intronic sequences, suggesting how TRAMP may directly promote pre-mRNA splicing. We propose that the requirement of TRAMP for an optimal pre-mRNA splicing efficiency may provide a fail-safe mechanism to ensure the timely recruitment of TRAMP to intronic sequences before or during splicing for the subsequent targeting of spliced-out introns to rapid degradation by the nuclear exosome.

MATERIALS AND METHODS
=====================

Yeast strains and plasmids
--------------------------

Yeast strains and plasmids used in this study are listed in [Supplementary Tables S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt888/-/DC1) and [S2](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt888/-/DC1), respectively. All gene deletions and epitope tagging were performed using standard homologous recombination techniques ([@gkt888-B47]). Epitope switching was done using a previously described method ([@gkt888-B48]). The *gal10*-Δ*56* mutation was generated as described elsewhere ([@gkt888-B49]).

Chromatin immunoprecipitation
-----------------------------

Chromatin immunoprecipitations (ChIPs) were performed as previously described ([@gkt888-B50]) with slight modifications. First, 30 ml of yeast cultures at a A~600~ of 0.6--0.8 were crosslinked with 1% formaldehyde at room temperature for 15 min, followed by centrifugation at 4000 rpm for 5 min, and then the cell pellets were washed twice with 30 ml of 1X TBS. The cells were subsequently lysed in FA lysis buffer (50 mM HEPES-KOH (pH 7.5), 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na deoxycholate and addition of protease inhibitors) with the help of glass beads by vigorous vortexing at 4°C for 45 min. Cell lysates were then sonicated using a Sonics Vibra-cell sonicator for a total of 5 min, with 9 s rest after every 9 s of sonication, followed by centrifugation at 13 200 rpm for 15 min. The supernatants were then used as the input for immunoprecipitations with either 40 µl of rabbit IgG agarose beads (Sigma, Cat \#A2909) (for TAP-tagged proteins) or 1 µl of Anti-Rpb3p antibodies (Neoclone, Cat \#W0012) (pre-incubated with 40 µl of Anti-mouse magnetic beads {Invitrogen, Cat \#112-02D}) for 2 h at 4°C. After that, beads were washed twice with FA lysis buffer, followed by twice with wash buffer II (50 mM HEPES-KOH (pH 7.5), 500 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na deoxycholate), then twice with wash buffer III (10 mM Tris-HCl (pH 8.0), 250 mM LiCl, 1 mM EDTA, 0.5% NP-40, 0.5% Na deoxycholate), and finally once with TE (10 mM Tris-HCl (pH 8.0), 1 mM EDTA). Then 250 µl of elution buffer (10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 0.67% SDS) was added to the beads, while at the same time 50 µl of input cell lysates were also mixed with 200 µl of elution buffer, and then both input and IP samples were put into a 65°C water bath for 12 h to reverse crosslink. Following that, the chromatin fragments within the input and IP samples were purified by standard phenol-chloroform extraction procedures followed by ethanol precipitation, and the resulting DNA pellets were resuspended in 20 µl of H~2~O. Finally, the immunoprecipitated and input DNAs were analysed simultaneously by either radioactive PCR or quantitative PCR (qPCR). In the case of radioactive PCR, each reaction contained (^33^P)-labeled dCTP and two pairs of primers that amplified both a target region and the control region *ChrV*, in addition to standard PCR reaction components. PCR products were separated by 6% acrylamide gels, then exposed to phosphor screen after gel drying, and signals were detected by a phosphor imager with band intensities being later quantified using the associated software. Occupancies were then calculated by the following formula: (IP~target~/IP~ChrV~) ÷ (Input~target~/Input~ChrV~). In the case of qPCR, diluted DNA samples were analysed using the SYBR Green method (SYBR® Premix Ex Taq™ from TaKaRa) with the StepOnePlus™ Real-Time PCR Systems from Applied Biosystems, according to manufacturer's instructions. Occupancies were then calculated by the following formula: 2^Ct(IP:ChrV)--Ct(IP:target)^÷ 2^Ct(Input:ChrV)--^ ^Ct(Input:target)^. All primers used are listed in [Supplementary Table S3](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt888/-/DC1).

RNA analysis
------------

Total RNAs were extracted using standard hot phenol RNA preparation method ([@gkt888-B51]). For RT-PCR analysis, 1.5 µg of total RNAs were subjected to reverse transcription (RT) using gene-specific primers, and then the resulting cDNAs were analysed by standard PCR method or qPCR. Primers used are listed in [Supplementary Table S3](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt888/-/DC1). The half-life of pre-mRNAs was determined as described previously ([@gkt888-B52],[@gkt888-B53]). For northern blotting, the procedures were as previously described ([@gkt888-B50]) except that total RNAs (10 µg) were separated by 6% acrylamide gels. Sequences of oligonucleotide probes are listed in [Supplementary Table S3](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt888/-/DC1). Band intensities were quantified using ImageJ densitometry software.

*lacZ* reporter assay
---------------------

Overnight yeast cultures were diluted into 30 ml of SC medium containing 2% raffinose but lacking uracil or both uracil and leucine to a A~600~ of ∼0.15, and then induced with 2% galactose for 2 h when A~600~ reached 0.3--0.5. After that, yeast cells were lysed by standard freeze-thaw procedures using liquid nitrogen, followed by β-galactosidase activity measurement using chemiluminescent method ([@gkt888-B54]).

GLAM assay
----------

GLAM assay was conducted as described previously ([@gkt888-B50]) using yeast cultures at an A~600~ of 0.3--0.5.

Coimmunoprecipitation
---------------------

CoIP was performed as described previously ([@gkt888-B55]), except that cell lysates were immunoprecipitated with 40 µl of rabbit IgG agarose beads (Sigma, Cat \#A2909).

Western blotting
----------------

Western blotting was performed as described previously ([@gkt888-B56]) except that yeast cells were lysed in FA lysis buffer.

RESULTS
=======

TRAMP is required for optimal splicing of an intron-containing *lacZ* reporter transcript
-----------------------------------------------------------------------------------------

To explore the possible role of TRAMP in pre-mRNA splicing, we used a previously described splicing-dependent *lacZ* reporter system ([@gkt888-B33],[@gkt888-B34],[@gkt888-B57]) to measure splicing efficiency in yeast strains with or without a functional TRAMP complex. This system is composed of three reporter plasmids, with each of them bearing a GAL-promoter-driven *lacZ* reporter gene ([Figure 1](#gkt888-F1){ref-type="fig"}A) ([@gkt888-B32]). The *lacZ* gene in pLGSD5 is intronless, and its encoded β-galactosidase activity serves as a control to normalize the differences in plasmid copy number and translation efficiency among different yeast strains. The *lacZ* gene in Acc° contains an intron close to the 5′ end, and due to differences in translational frame, only the spliced mRNAs, but not the unspliced pre-mRNAs, can be translated into functional β-galactosidase. The activity from Acc° after normalization to that from pLGSD5 provides a quantitative measure of the spliced mRNA level, which represents the efficiency of pre-mRNA splicing. The *lacZ* gene in Nde°Acc° contains one more nucleotide than Acc° at the intron--exon junction, with the 'T' nucleotide in Acc° being changed into 'CG' in Nde°Acc° (underlined), and as a result of translational frame-shift, only the unspliced pre-mRNAs from Nde°Acc° (if it is exported into the cytoplasm) can express β-galactosidase. After normalization to pLGSD5, the activity from Nde°Acc° represents the level of unspliced pre-mRNAs in the cytoplasm, which increases when there are splicing defects, pre-mRNA degradation defects, and/or pre-mRNA leakage from the nucleus. In theory, defects in pre-mRNA splicing should reduce the level of spliced mRNAs and elevate the level of unspliced pre-mRNAs, leading to a decreased activity from Acc° but an increased activity from Nde°Acc° after normalization to the activity from pLGSD5. Figure 1.Optimal splicing of an intron-containing *lacZ* reporter transcript is dependent on a functional TRAMP complex. (**A**) Structure of the three reporter constructs in the relevant *lacZ* reporter system, and the abilities of their encoded RNAs to be translated into functional β-galactosidase. (**B--C**) Results of the *lacZ* reporter assays. Yeast strains with the indicated genotypes transformed with the appropriate reporter plasmids were grown in SC medium containing 2% raffinose but lacking uracil until A~600~ reached 0.3--0.5, then induced with 2% galactose for 2 h, followed by measurement of β-galactosidase activity. The β-galactosidase activity from strains transformed with either Nde°Acc° (panel B) or Acc° (panel C) are shown relative to the activities in the same strain transformed with pLGSD5 after normalization to total protein concentration in the cell lysates. The differences in β-galactosidase activity between the indicated strains with wild-type were shown to be statistically significant by Student's *t*-test (\* represents *P* \< 0.05 and \*\* represents *P* \< 0.01). (**D**) Semi-quantitative RT-PCR analysis of the unspliced pre-mRNAs (Un) and spliced mRNAs (S) transcribed from the intron-containing *lacZ* gene on Acc°. A reverse primer located within exon 2 was used for RT, and the same primer was used together with a forward primer located within exon 1 for PCR amplification. The positions of unspliced pre-mRNAs and spliced mRNAs are indicated by the arrows on the right. Band intensities were quantified by ImageLab software, and the numbers below represent the ratio of PCR products produced from the unspliced pre-mRNAs to that of the spliced mRNAs after normalization to wild-type. (**E--F**) Similar to panel C but with cells being grown in SC medium lacking both uracil and leucine. All *lacZ* reporter results shown represent the average from at least four independent yeast cultures, with error bars showing the standard errors of the mean.

As expected, deletion of the gene encoding TRAMP components (Trf4p or both Air1p and Air2p) or the nuclear exosome component Rrp6p, which are involved in pre-mRNA degradation ([@gkt888-B36]), and that encoding Cbp80p, which promotes the recruitment of splicing factors to introns ([@gkt888-B40],[@gkt888-B58]), led to an increased relative β-galactosidase activity from Nde°Acc° to pLGSD5 (unspliced pre-mRNA level) ([Figure 1](#gkt888-F1){ref-type="fig"}B) due to the accumulation of unspliced pre-mRNAs. As a positive control, the reduced splicing efficiency in *cbp80*Δ cells ([@gkt888-B40],[@gkt888-B58]) could be shown by a decreased relative β-galactosidase activity from Acc° to pLGSD5 (spliced mRNA level) ([Figure 1](#gkt888-F1){ref-type="fig"}C). Interestingly, deletion of *RRP6*, and that of *TRF4* or both *AIR1* and *AIR2*, resulted in distinct readouts of the Acc° reporter. The relative activity from Acc° to pLGSD5 (spliced mRNA level) was unchanged when *RRP6* was deleted ([Figure 1](#gkt888-F1){ref-type="fig"}C). Thus, the increased relative activity from Nde°Acc° to pLGSD5 ([Figure 1](#gkt888-F1){ref-type="fig"}B), which represented an accumulation of unspliced pre-mRNAs in *rrp6*Δ cells, could be best attributed to a decreased pre-mRNA degradation rate. The absence of splicing defects in *rrp6*Δ cells also excluded the possibility that reduced turnover of abnormal splicing intermediates or unspliced pre-mRNAs ([@gkt888-B36]) may indirectly compromise splicing by sequestrating the splicing machinery. In contrast, deletion of *TRF4* or both *AIR1* and *AIR2* significantly reduced the relative activity from Acc° to pLGSD5 (spliced mRNA level) to an extent similar to that evoked by deletion of *CBP80* ([Figure 1](#gkt888-F1){ref-type="fig"}C), indicating the presence of splicing defects in *trf4*Δ and *air1Δair2*Δ cells. To ensure that such observed changes of the activity of *lacZ* reporters were accurately reflecting the changes in RNA levels, we used RT-PCR analysis to directly measure the amount of the unspliced and spliced *lacZ* RNAs. Although both the deletion of TRAMP components and that of Rrp6p would give rise to an increased unspliced to spliced RNA ratio ([Figure 1](#gkt888-F1){ref-type="fig"}D), the underlying causes for this phenotype were different. The increased unspliced to spliced RNA ratio associated with the deletion of *TRF4* or both *AIR1* and *AIR2* was due to the accumulation of unspliced pre-mRNAs and the decline of spliced mRNAs ([Figure 1](#gkt888-F1){ref-type="fig"}D), as also shown by the *lacZ* reporter results presented in [Figures 1](#gkt888-F1){ref-type="fig"}B and C, respectively, consistent with the presence of splicing defects. On the other hand, the increased unspliced to spliced RNA ratio in *rrp6*Δ cells was the consequence of pre-mRNA accumulation but not changes in spliced mRNA levels ([Figure 1](#gkt888-F1){ref-type="fig"}D), which agreed with the *lacZ* reporter results shown in [Figures 1](#gkt888-F1){ref-type="fig"}B and C and was consistent with the known pre-mRNA degradation defects in *rrp6*Δ cells. Furthermore, the reduced relative activity from Acc° to pLGSD5 (spliced mRNA level) in *trf4*Δ and *air1Δair2*Δ cells could be rescued by wild-type *TRF4* ([Figure 1](#gkt888-F1){ref-type="fig"}E) or *AIR1* ([Figure 1](#gkt888-F1){ref-type="fig"}F), respectively. Thus, although TRAMP is a well-defined cofactor of the nuclear exosome ([@gkt888-B3]), our results suggested that TRAMP can facilitate the splicing of an intron-containing *lacZ* reporter transcript in a nuclear-exosome-independent manner.

TRAMP is cotranscriptionally recruited to the *lacZ* reporter transcript with enrichment over intronic sequences
----------------------------------------------------------------------------------------------------------------

To examine whether TRAMP directly facilitates splicing of the intron-containing *lacZ* reporter transcript, we used ChIP to analyse the cotranscriptional recruitment patterns of TAP-tagged TRAMP component Air2p at the galactose-inducible intron-containing *lacZ* reporter gene on Acc° and its intronless version on pLGSD5 ([Figure 2](#gkt888-F2){ref-type="fig"}A). Cotranscriptional recruitment of Air2p-TAP was detected along the entire coding sequences of both *lacZ* reporter genes ([Figure 2](#gkt888-F2){ref-type="fig"}B and C) when their transcription was induced in the presence of galactose. The high occupancy of the RNA polymerase II subunit Rpb3p ([Figure 2](#gkt888-F2){ref-type="fig"}B and D) confirmed that both genes were actively transcribing. Air2p-TAP occupancy observed at the intronless *lacZ* reporter gene on pLGSD5 ([Figure 2](#gkt888-F2){ref-type="fig"}C) closely followed that of Rpb3p ([Figure 2](#gkt888-F2){ref-type="fig"}D), leading to a uniform Air2p-TAP to Rpb3p occupancy ratio along the coding sequences ([Figure 2](#gkt888-F2){ref-type="fig"}E). Notably, the occupancy of Air2p-TAP at the intronic region (region A) on Acc° was significantly higher than the respective intronless region (region A) on pLGSD5 ([Figure 2](#gkt888-F2){ref-type="fig"}B and C), implying that the presence of an intron can enhance Air2p-TAP occupancy. This effect became even more obvious ([Figure 2](#gkt888-F2){ref-type="fig"}E) after normalization to the occupancy of Rpb3p ([Figure 2](#gkt888-F2){ref-type="fig"}D). Figure 2.TRAMP is cotranscriptionally recruited to the intron-containing *lacZ* reporter transcript with enrichment over intronic sequences. (**A**) Schematic diagram of the intron-containing *lacZ* gene on Acc° and the intronless *lacZ* gene on pLGSD5, showing regions subjected to ChIP analysis. The numbers shown represent the number of nucleotides away from the start codon. (**B--E**) Air2p-TAP strain harboring the indicated plasmids were grown in SC medium lacking uracil but containing 2% raffinose, with the addition of 2% galactose to the medium 1.5 h before crosslinking, and then subjected to ChIP analysis using radioactive PCR. Representative results for region A are shown in (B). Radiolabeled amplicons were quantified by phosphorimaging and the ratios of target to *ChrV* signals in the Air2p-TAP and Rpb3p immunoprecipitations (IPs) were normalized to that in the corresponding inputs to yield the occupancy values presented in (C) and (D), respectively. The Air2p-TAP occupancies shown in (C) were divided by the Rpb3p occupancies shown in (D) to yield the Air2p-TAP to Rpb3p occupancy ratios shown in (E). (**F--G**) ChIP analysis as in (B--E) but with cell lysates being treated with or without RNase A for 30 min at room temperature before immunoprecipitation with IgG agarose beads. Chromatin fragments of region A and *ChrV* were analysed by PCR without radiolabeling, and the amplicons were visualized by ethidium bromide (EtBr) staining followed by quantification using ImageLab software. Representative results are shown in (F), and Air2p-TAP occupancies relative to that at pLGSD5 without RNase A treatment were plotted in (G). The differences in Air2p-TAP occupancy and Air2p-TAP to Rpb3p occupancy ratio between pLGSD5 and Acc° were shown to be statistically significant using Student's *t*-test (\* represents *P* \< 0.05 and \*\* represents *P* \< 0.01). All results shown represent the average from three independent cultures, with error bars showing the standard errors of the mean.

We also investigated whether binding of TRAMP to the intronic region is RNA dependent. To address this question, ChIP analysis was performed using cell lysates being treated with or without RNase A before the immunoprecipitation step ([@gkt888-B59],[@gkt888-B60]). Consistent with the result shown in [Figure 2](#gkt888-F2){ref-type="fig"}C, Air2p-TAP occupancy was significantly higher at region A on Acc° than that on pLGSD5 for cell lysates without RNase A treatment ([Figure 2](#gkt888-F2){ref-type="fig"}F and G). The enrichment of Air2p-TAP at region A on both Acc° and pLGSD5 was substantially decreased by the treatment of RNase A ([Figure 2](#gkt888-F2){ref-type="fig"}F and G), indicating that TRAMP binds directly to the nascent RNA transcript (but not the surrounding chromatin DNA) during transcription. The cotranscriptional recruitment of TRAMP to the nascent intron-containing *lacZ* reporter transcript with enrichment over intronic sequences probably implicated a direct stimulatory role of TRAMP in pre-mRNA splicing.

TRAMP recruitment to endogenous intron-containing transcripts is also enriched at intronic sequences
----------------------------------------------------------------------------------------------------

After demonstrating the cotranscriptional recruitment of TRAMP to the intron-containing *lacZ* reporter transcript, we asked whether TRAMP is also cotranscriptionally recruited to RNA transcripts transcribed from endogenous intron-containing genes. ChIP was performed to investigate the cotranscriptional recruitment of Air2p-TAP to the RNA transcripts synthesized from the intron-containing genes *RPL18B* and *RPS9A* ([Figure 3](#gkt888-F3){ref-type="fig"}A and E), in which their corresponding spliced-out introns have been previously shown to be recognized by TRAMP using RNA-IP-chip analysis ([@gkt888-B45]). Air2p-TAP occupancy at all examined regions along both *RPL18B* and *RPS9A* was significantly higher than that of the no-tag control ([Figure 3](#gkt888-F3){ref-type="fig"}B and F), indicating that Air2p-TAP is also recruited to the RNA transcripts transcribed from these endogenous intron-containing genes. However, since both *RPL18B* and *RPS9A* genes are relatively short (∼1000 bp) and thus limited the resolution of the ChIP assay, there were no detectable effects of the presence of intron on Air2p-TAP recruitment ([Figure 3](#gkt888-F3){ref-type="fig"}A--H). To overcome this problem, the longer intron-containing genes *ECM33* and *DBP2* were also analysed. In addition, recruitment of the TRAMP components Air1p-TAP and Trf4p-TAP, as well as the nuclear exosome component Rrp6p-TAP, was also examined. Figure 3.TRAMP is cotranscriptionally recruited to nascent RNAs transcribed from endogenous intron-containing genes, with higher occupancy at intronic regions. (**A**, **E**, **I**, **M**) Schematic diagram of the intron-containing genes *RPL18B* (A), *RPS9A* (E), *ECM33* (I) and *DBP2* (M), showing regions subjected to ChIP analysis. The numbers shown represent the number of nucleotides away from the start codon. (**B**, **F**, **J**, **N**) Indicated yeast strains were grown in YPD medium to log-phase and then subjected to ChIP analysis using IgG agarose beads. The purified input and immunoprecipitated chromatin fragments were analysed by qPCR. The calculated occupancy values at the targeted regions (relative to a non-coding region in *ChrV*) for the indicated TAP-tagged proteins were plotted after normalization to the no-tag control. (**C**, **G**, **K**, **O**) The same lysates used in (B, F, J, N) were subjected to ChIP analysis using Anti-Rpb3p antibodies, yielding the plotted Rpb3p occupancy values. (**D**, **H**, **L**, **P**) The occupancies for the indicated TAP-tagged proteins shown in (B, F, J, N) were further normalized to the corresponding Rpb3p occupancies shown in (C, G, K, O) to calculate the TAP/Rpb3p occupancy ratios. The differences between Air2p-TAP and the untagged control in (B, D, F, H), and those between the indicated pairs of regions along *ECM33* or *DBP2* in (J, L, N, and P), were shown to be statistically significant using Student's *t*-test (\* represents *P* \< 0.05 and \*\* represents *P* \< 0.01). All results shown represent the average from three independent cultures, with error bars showing the standard errors of the mean.

At *ECM33* ([Figure 3](#gkt888-F3){ref-type="fig"}I), in which the intron is located near the 5′ end just as that of the intron-containing *lacZ* reporter gene on Acc° ([Figure 2](#gkt888-F2){ref-type="fig"}A), the recruitment levels of TRAMP and Rrp6p were the highest (∼2.0--2.5-fold) at positions near the intron (regions A and B), but decreased to ∼1.5-fold at the middle (region C) or 3′ end (region D) of the long exon 2 ([Figure 3](#gkt888-F3){ref-type="fig"}J). The changes in TRAMP and Rrp6p occupancy along *ECM33* were not due to differences in transcription activity ([Figure 3](#gkt888-F3){ref-type="fig"}K), as the occupancy of TRAMP and Rrp6p was still enriched at positions near the intron after normalization to Rpb3p occupancy ([Figure 3](#gkt888-F3){ref-type="fig"}L). At *DBP2* ([Figure 3](#gkt888-F3){ref-type="fig"} M), in which the intron is located at the middle of the gene closer to the 3′ end, both Air1p-TAP and Air2p-TAP occupancy remained at ∼1.5-fold along exon 1 (regions A and B), and then increased to ∼2.0--2.5-fold within (region C) or just downstream of the intron (region D) ([Figure 3](#gkt888-F3){ref-type="fig"}N). Both Trf4p-TAP and Rrp6p-TAP also showed similar recruitment pattern ([Figure 3](#gkt888-F3){ref-type="fig"}N), although the effect of the intron appeared to be smaller, probably because their binding to the intron should be mediated through Air1/2p. After normalization to Rpb3p occupancy ([Figure 3](#gkt888-F3){ref-type="fig"}O), the enrichment of TRAMP and Rrp6p occupancy within or just downstream of the *DBP2* intron became even more prominent ([Figure 3](#gkt888-F3){ref-type="fig"}P). To summarize, these results clearly demonstrated that the cotranscriptional recruitment of both TRAMP and the nuclear exosome to nascent RNA transcripts are enriched at the intronic region of each gene, irrespective of its presence near the 5′ end \[as for the intron-containing *lacZ* gene on Acc° ([Figure 2](#gkt888-F2){ref-type="fig"}) and *ECM33* ([Figure 3](#gkt888-F3){ref-type="fig"}I--L)\] or the 3′ end \[as for *DBP2* ([Figure 3](#gkt888-F3){ref-type="fig"}M--P)\], suggesting that spliced-out introns, and probably also splicing-defective pre-mRNAs, may already be captured by TRAMP and committed to subsequent nuclear-exosome-mediated degradation during transcription (i.e. very likely before or during splicing). The cotranscriptional recruitment of TRAMP to RNA transcripts synthesized from endogenous intron-containing genes also led to the hypothesis that TRAMP may enhance the splicing of endogenous unspliced pre-mRNAs.

Pre-mRNA splicing is facilitated by TRAMP
-----------------------------------------

To test whether TRAMP is needed for optimal splicing of endogenous unspliced pre-mRNAs, we performed RT-qPCR to monitor the level of the unspliced *RPL18B* and *ECM33* pre-mRNAs in yeast strains with or without deletion of TRAMP components. Consistent with the *lacZ* reporter results ([Figure 1](#gkt888-F1){ref-type="fig"}B) and the requirement of nuclear exosome for unspliced pre-mRNA turnover ([@gkt888-B36]), both *RPL18B* and *ECM33* pre-mRNAs accumulated in yeast cells lacking Rrp6p (∼4.5-fold for *RPL18B* and ∼2.0-fold for *ECM33*) ([Figure 4](#gkt888-F4){ref-type="fig"}A and B). Deletion of the TRAMP components *TRF4* or both *AIR1* and *AIR2* resulted in a moderately greater extent of pre-mRNA accumulation (∼6.0-fold for *RPL18B* and ∼3.0-fold for *ECM33*) ([Figure 4](#gkt888-F4){ref-type="fig"}A and B) than that of *RRP6*, suggesting that TRAMP may have an additional role in regulating pre-mRNA levels in addition to its plausible role in stimulating Rrp6p-dependent pre-mRNA turnover. Semi-quantitative RT-PCR analysis also revealed that the unspliced pre-mRNAs to spliced mRNAs ratio of *RPL18B* is significantly greater in *trf4*Δ and *air1Δair2*Δ as compared to wild-type or even the splicing-compromised *cbp80*Δ cells ([@gkt888-B40],[@gkt888-B58]) ([Figure 4](#gkt888-F4){ref-type="fig"}C). There was no pre-mRNA accumulation in the *trf5*Δ strain ([Figure 4](#gkt888-F4){ref-type="fig"}C), probably because the presence of Trf4p may completely compensate for the loss of Trf5p, as suggested by previous studies ([@gkt888-B45],[@gkt888-B61]). The observed increase in the *RPL18B* pre-mRNAs/mRNAs ratio in *trf4*Δ cells could be almost completely rescued by addition of the wild-type *TRF4* gene ([Figure 4](#gkt888-F4){ref-type="fig"}D), while that in *air1Δair2*Δ cells could be partially complemented by either the *AIR1* or the *AIR2* gene ([Figure 4](#gkt888-F4){ref-type="fig"}D), further confirming that TRAMP is required for pre-mRNA metabolism. Figure 4.Deletion of TRAMP components resulted in accumulation of endogenous unspliced pre-mRNAs largely independent of impaired Rrp6p or Dis3p activity in the absence of TRAMP components. (**A--B**) RT-qPCR analysis of the unspliced pre-mRNAs transcribed from *RPL18B* (panel A) and *ECM33* (panel B) in yeast strains with the indicated genotypes. Total RNAs extracted from log-phase yeast cultures were subjected to DNase I treatment and then RT using gene-specific primers located within exon 2, followed by qPCR analysis of cDNAs using a forward primer located within the intron and a reverse primer identical to that used in RT. The *PMA1* transcript was also analysed in parallel to serve as an internal control. The relative unspliced pre-mRNA levels after normalization to that of *PMA1* were shown. (**C--D**) The cDNAs originating from yeast strains with the indicated genotypes were analysed by semi-quantitative PCR to detect the levels of the unspliced (Un) and spliced (S) *RPL18B* transcripts (with their positions shown on the right). Band intensities were quantified using ImageLab software, and the relative ratios of unspliced to spliced transcripts were shown at the bottom. (**E--H**) Same as (A--B) but using primers that can amplify the indicated unspliced pre-mRNAs. (**I--J**) Same as (C--D) but using primers that can amplify the indicated unspliced pre-mRNAs (Un) and spliced mRNAs (S). (**K--L**) Same as (E) and (G) but using yeast strains with the indicated genotypes that were grown either in the absence (-DOX) or presence (+DOX) of doxycycline (20 µg/ml) for 8 h from the early-log phase. All yeast strains with the Tet-Off *DIS3* allele also contained a plasmid expressing a mutant form of Dis3p with simultaneous mutations in both catalytic domains (D171N-D551N). Student's *t*-test was applied to confirm that the differences in pre-mRNA levels between the indicated yeast strains and wild-type (A--B, E--H), or between the indicated pairs of yeast strains (K--L), were statistically significant (\* represents *P* \< 0.05 and \*\* represents *P* \< 0.01). All qPCR results shown represent the average from three independent cultures, with error bars showing the standard errors of the mean.

In order to determine whether pre-mRNA accumulation observed in *trf4*Δ and *air1Δair2*Δ cells was due at least partially to the involvement of TRAMP in Rrp6p-independent pathways, we also examined in these cells the level of several other unspliced pre-mRNAs which do not require Rrp6p for their normal turnover ([@gkt888-B37]). The deletion of *RRP6* had no effects on the level of the *RPL16B*, *RPL39*, *RPL21A* and *RPS18A* pre-mRNAs ([Figure 4](#gkt888-F4){ref-type="fig"}E--H), consistent with previous report that Rrp6p is not involved in their degradation ([@gkt888-B37]). Importantly, the deletion of *TRF4* or both *AIR1* and *AIR2* led to significant increments (∼1.5--2.0-fold) in the level of these unspliced pre-mRNAs ([Figure 4](#gkt888-F4){ref-type="fig"}E--H), with the accumulation of *RPL16B* and *RPL21A* pre-mRNAs being further confirmed using semi-quantitative RT-PCR analysis of their pre-mRNAs/mRNAs ratio ([Figure 4](#gkt888-F4){ref-type="fig"}I and J). These results suggested that pre-mRNA accumulation observed in *trf4*Δ and *air1Δair2*Δ cells was largely independent of the role of TRAMP in enhancing Rrp6p-mediated pre-mRNA turnover.

In addition to Rrp6p, the nuclear exosome contains another catalytic subunit known as Dis3p (or Rrp44p) ([@gkt888-B1],[@gkt888-B2],[@gkt888-B6]), which is also involved in the degradation of pre-mRNAs and CUTs such as *NEL025c* ([@gkt888-B13]). As *DIS3* is an essential gene, we used a doxycycline-repressible promoter system to deplete the expression of endogenous *DIS3*, which effectiveness could be shown by the huge accumulation of *NEL025c* transcripts upon the addition of doxycycline ([Supplementary Figure S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt888/-/DC1)). Using the same experimental system, we observed a slight increase (∼1.5-fold) in *RPL16B and RPL21A* pre-mRNA levels ([Figure 4](#gkt888-F4){ref-type="fig"}K and L) upon *DIS3* depletion. Note that in order to rule out the possibility that depletion of Dis3p might affect its non-catalytic functions, a catalytically inactive Dis3p mutant (D171N-D551N) was constitutively expressed in the endogenous Dis3p-depleted strains. We next asked whether the accumulation of *RPL16B and RPL21A* pre-mRNAs in TRAMP-defective cells ([Figure 4](#gkt888-F4){ref-type="fig"}E and G) was simply due to the loss of the theoretically possible stimulation of Dis3p activity by TRAMP, although this was very unlikely as it has been previously reported that TRAMP can facilitate the action of Rrp6p but not that of Dis3p or the core exosome ([@gkt888-B62]). We found that further deletion of *TRF4* from yeast strain already carrying both deletion of *RRP6* and doxycycline-repressible *DIS3* gene still resulted in significant *RPL16B and RPL21A* pre-mRNA accumulation even when *DIS3* expression was depleted by doxycycline treatment ([Figure 4](#gkt888-F4){ref-type="fig"}K and L). This finding indicated that pre-mRNA accumulation associated with TRAMP component deletion was largely unattributed to the possible role of TRAMP in enhancing Rrp6p- or Dis3p-mediated pre-mRNA degradation. Therefore, we concluded that most of the accumulated *RPL16B*, *RPL39*, *RPL21A* and *RPS18A* pre-mRNAs, and at least a small portion of the accumulated *RPL18B* and *ECM33* pre-mRNAs, observed in *trf4*Δ and *air1Δair2*Δ cells were due to splicing defects. These results provided strong evidences implicating the moonlighting function of TRAMP in promoting efficient splicing of endogenous pre-mRNAs.

Pursuing these, we further analysed the effect of deletion of TRAMP components on the half-life of pre-mRNAs. Since a newly synthesized pre-mRNA should either be spliced into mature mRNA ([@gkt888-B31]) or degraded into ribonucleotides \[may occur in the nucleus ([@gkt888-B36]) or after export into cytoplasm ([@gkt888-B37])\], half-life of the pre-mRNA is dependent on both its splicing efficiency and the rate of its degradation. After transcriptional shut-off with thiolutin ([@gkt888-B52],[@gkt888-B53]), the *RPL18B* pre-mRNAs are spliced and/or degraded with a half-life of ∼7.4 min ([Figure 5](#gkt888-F5){ref-type="fig"}A). Consistent with its role in the degradation of *RPL18B* pre-mRNAs, deletion of *RRP6* significantly prolonged its half-life to ∼11.0 min ([Figure 5](#gkt888-F5){ref-type="fig"}A). In agreement with a stimulatory role of TRAMP in both the splicing of *RPL18B* pre-mRNAs and their Rrp6p-mediated degradation, *trf4*Δ and *air1Δair2*Δ cells showed an even longer *RPL18B* pre-mRNA half-life (∼12.1 min for *trf4*Δ and ∼16.3 min for *air1Δair2*Δ) as compared to *rrp6*Δ cells (∼11.0 min) ([Figure 5](#gkt888-F5){ref-type="fig"}A). The half-life of *RPL16B* and *RPL21A* pre-mRNAs in these yeast strains was also consistent with their steady-state levels. Both *RPL16B* and *RPL21A* pre-mRNAs had a half-life of ∼8.2 min in wild-type cells, and their half-life remained unaffected in *rrp6*Δ ([Figure 5](#gkt888-F5){ref-type="fig"}B and C), in accordance with that Rrp6p is not required for their normal turnover ([Figure 4](#gkt888-F4){ref-type="fig"}E--J) ([@gkt888-B37]). In contrast, their half-life was significantly prolonged to \>10.0 min in *trf4*Δ and *air1Δair2*Δ cells ([Figure 5](#gkt888-F5){ref-type="fig"}B and C), suggesting that their splicing efficiency (but not degradation rate since their half-life was not affected in *rrp6*Δ) was compromised. Thus, the analysis of endogenous unspliced pre-mRNA half-life after transcription inhibition with thiolutin also supported that pre-mRNA splicing is facilitated by TRAMP. Figure 5.Analysis of the half-life of endogenous unspliced pre-mRNAs and the accumulation rate of spliced *lacZ* mRNAs in yeast strains lacking TRAMP components or Rrp6p. (**A--C**) Yeast cells with the indicated genotypes were harvested at different time points after the addition of thiolutin (4 µg/ml) to inhibit transcription. The cDNAs prepared from these cells were subjected to qPCR analysis to determine the levels of the indicated pre-mRNAs and the internal control *SCR1*. The amount of pre-mRNAs remaining in the cells after normalization to *SCR1* were expressed in terms of the percentage of the pre-mRNA level at *t* = 0. The estimated pre-mRNA half-life and its standard errors of the mean are shown at the bottom. (**D**) The indicated yeast strains transformed with the Acc° reporter plasmid were first grown in SC medium containing 2% raffinose but lacking uracil, and then harvested at different time points after the addition of 2% galactose to induce expression of the intron-containing *lacZ* gene on Acc°. After that, RT-qPCR analysis was performed to measure the levels of the spliced *lacZ* mRNAs (with the forward primer being complementary to the exon 1--exon 2 junction) and also *SCR1*. The spliced *lacZ* mRNA levels at the indicated time points were shown after normalization to *SCR1*, with the relative amount of spliced mRNAs at *t* = 0 being set at 1.0 for each yeast strain. Student's *t*-test was used to demonstrate that the indicated differences were statistically significant (\* represents *P* \< 0.05 and \*\* represents *P* \< 0.01). All results shown represent the average from three independent cultures, with error bars showing the standard errors of the mean.

To further confirm the stimulatory role of TRAMP in splicing, we also measured the accumulation rate of the spliced *lacZ* mRNAs synthesized from the intron-containing *lacZ* gene on the Acc° reporter plasmid when its expression was induced by galactose. As expected, the spliced *lacZ* mRNA level increased sharply in wild-type cells after galactose addition ([Figure 5](#gkt888-F5){ref-type="fig"}D). The deletion of *RRP6* did not significantly affect its rate of accumulation ([Figure 5](#gkt888-F5){ref-type="fig"}D), consistent with our finding that Rrp6p is not involved in pre-mRNA splicing ([Figure 1](#gkt888-F1){ref-type="fig"}C). Importantly, there was a severe delay in the accumulation of the spliced *lacZ* mRNAs in *trf4*Δ and *air1Δair2*Δ cells ([Figure 5](#gkt888-F5){ref-type="fig"}D). This effect was not due to defective induction of the *GAL* promoter, as there were no significant changes in the accumulation rate of *GAL10* mRNAs in the absence of TRAMP components ([Supplementary Figure S2A](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt888/-/DC1)). Thus, the induction time profile of the spliced *lacZ* mRNAs remained significantly delayed in the TRAMP-defective cells even after normalization to that of *GAL10* mRNAs ([Supplementary Figure S2B](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt888/-/DC1)), which again, indicated that TRAMP is required for optimal splicing of pre-mRNAs.

Splicing defects associated with deletion of TRAMP components are not due to defects in transcription elongation
----------------------------------------------------------------------------------------------------------------

Pre-mRNA splicing and transcription elongation are tightly linked processes ([@gkt888-B63]). Since TRAMP components physically associate with subunits of the THO complex ([@gkt888-B27]) and the Ccr4-Not complex ([@gkt888-B66]), which are both involved in transcription elongation ([@gkt888-B67],[@gkt888-B68]), we first examined whether TRAMP may indirectly regulate splicing by affecting transcription elongation rate.

The Δ56 mutation within the *GAL10* 3′-UTR of normal cells results in transcriptional read-through into the downstream *GAL7* gene ([Figure 6](#gkt888-F6){ref-type="fig"}A), rendering a Gal-- phenotype (unable to grow on galactose-containing medium) that can be rescued by the deletion of transcription elongation factors ([@gkt888-B49]) or anti-termination factors ([@gkt888-B69]). The deletion of both Air1p and Air2p did not detectably rescue the Gal-- phenotype ([Figure 6](#gkt888-F6){ref-type="fig"}B), suggesting that TRAMP is not involved in transcription elongation. In addition, transcription elongation defects could only be detected in the positive control *npl3*Δ ([@gkt888-B70]) but not in *trf4*Δ and *air1Δair2*Δ cells ([Figure 6](#gkt888-F6){ref-type="fig"}C) using a well-established assay for gene-length dependent accumulation of mRNA (GLAM) to measure transcription elongation rate ([@gkt888-B71]), thus further excluding the possibility that TRAMP may facilitate pre-mRNA splicing by participating in transcription elongation. Figure 6.Splicing defects in *trf4*Δ and *air1Δair2*Δ are not due to defects in transcription elongation or snRNA synthesis. (**A**) Schematic diagram explaining the rationale of the *gal10Δ56* assay. In yeast strains without transcription elongation and/or anti-termination defects, the transcriptional read-through from the *GAL10* gene containing the Δ56 deletion in its 3′-UTR interferes with the proper transcription of the downstream *GAL7* gene, thus preventing the cells from growing on a medium that contains galactose as the only carbon source (Gal-- phenotype). In yeast strains with defects in transcription elongation and/or anti-termination, the impaired transcriptional read-through into *GAL7* partially restores *GAL7* transcription, thus allowing the cells to grow on the galactose-containing medium (Gal + phenotype). (**B**) Results of the *gal10Δ56* assay. Ten-fold serial dilutions of yeast cultures with the indicated genotypes were spotted onto SC-Leu agar plates containing either glucose or galactose as the only carbon source, and then incubated at 30°C or 37°C for 4 days. (**C**) Results of the GLAM assay. The acid phosphatase activity from the indicated yeast strains being transformed with pSCh209-LAC~4~ were divided by that from the same strain being transformed with pSCh202 to yield the GLAM ratio shown. The reduced GLAM ratio in *npl3*Δ cells was statistically significant by Student's *t*-test (\* represents *P* \< 0.05). The results represent the average from three independent cultures, with error bars showing the standard errors of the mean. (**D**) Northern blot analysis of both mature and precursor forms of U1, U4 and U5 snRNAs, and the loading control *SCR1*, on total RNAs extracted from log-phase cultures of the indicated yeast strains grown in YPD using (^32^P)-labeled oligonucleotide probes. For each snRNA, two images with different exposure time are shown to enable clear visualization of both mature and precursor forms, with their positions indicated on the right. Band intensities were quantified using ImageJ software, and the numbers at the bottom of each image represent the amount of mature or precursor forms of U1, U4 or U5 snRNAs, as indicated, relative to wild-type after normalization to the loading control *SCR1*. Note that mature U5 snRNA has two forms: U5~L~ represents the long form, while U5~S~ represents the short form.

Splicing defects associated with deletion of TRAMP components are not due to defective snRNA processing
-------------------------------------------------------------------------------------------------------

It has been previously demonstrated that the nuclear exosome is involved in the synthesis of U1, U4 and U5 small nuclear ribonucleic acids (snRNAs) from their precursors by 3′ end processing ([@gkt888-B72]), and that the TRAMP complex component Trf4p also contributes to U4 snRNA synthesis ([@gkt888-B73]). This raised the possibility that defects of pre-mRNA splicing caused by deletion of TRAMP components may be indirectly due to snRNA processing defects. However, northern blot analysis of U1, U4 and U5 snRNAs as well as their precursors revealed that the snRNA processing defects observed in cells lacking *TRF4* or both *AIR1* and *AIR2* were in all cases less severe than those observed in *rrp6*Δ cells. There was no detectable accumulation of U1 precursor in *trf4*Δ or *air1Δair2*Δ ([Figure 6](#gkt888-F6){ref-type="fig"}D, compare lanes 2 and 3 versus lane 1); and although both U4 and U5 precursors did accumulate in these cells, the phenotypes were significantly less severe than those in *rrp6*Δ cells, with an accumulation of only ∼2.0--3.0-fold for both U4 and U5 precursors in *trf4*Δ or *air1Δair2*Δ strains ([Figure 6](#gkt888-F6){ref-type="fig"}D, compare lanes 2 and 3 versus lane 1) compared to \>4.0-fold in *rrp6*Δ cells ([Figure 6](#gkt888-F6){ref-type="fig"}D, compare lane 4 with lane 1). As deletion of *RRP6* did not detectably affect splicing efficiency ([Figure 1](#gkt888-F1){ref-type="fig"}C), it is very unlikely that the splicing defects in *trf4*Δ and *air1Δair2*Δ strains arise from their less pronounced snRNA processing defects. Furthermore, the levels of the mature forms of U1, U4 and U5 snRNAs in these TRAMP knockout strains were in no cases less than the wild-type levels ([Figure 6](#gkt888-F6){ref-type="fig"}D, compare lanes 2 and 3 versus lane 1), indicating that there are sufficient or even excess snRNAs available for the splicing machinery. These results excluded the possibility that defective snRNA processing is the primary cause of the splicing defects observed in *trf4*Δ and *air1Δair2*Δ cells, and suggested a more direct stimulatory role for TRAMP in pre-mRNA splicing.

*TRF4* shows negative genetic interactions with the splicing factor genes *MUD2* and *MSL1*
-------------------------------------------------------------------------------------------

To explore whether there are any direct interactions between the TRAMP complex and the splicing machinery, we characterized the genetic interactions between *TRF4* and splicing factor genes. A previous genome-wide genetic interactions study suggested that *TRF4* may have a negative genetic interaction with *MUD2* ([@gkt888-B74]), which encodes the U2AF65 protein involved in polypyrimidine tract binding during splicing ([@gkt888-B31]). To verify this, we constructed the *TRF4* and *MUD2* deletion strains and characterized the genetic interaction between these mutations. The growth rate of yeast strain containing single deletion of *TRF4* (doubling time ∼3.9 h) was moderately slower than that of wild-type cells (doubling time ∼2.9 h), while the single deletion of *MUD2* (doubling time ∼2.9 h) had no detectable effect on growth rate ([Figure 7](#gkt888-F7){ref-type="fig"}A). However, the double deletion of both *TRF4* and *MUD2* resulted in a synthetic growth defect, with a growth rate (doubling time ∼4.6 h) much slower than that of *trf4*Δ ([Figure 7](#gkt888-F7){ref-type="fig"}A), indicating that negative genetic interaction exists between *TRF4* and *MUD2*. RT-PCR analysis revealed that while the single deletion of *MUD2* (∼1.1-fold) from wild-type cells did not result in any significant accumulation of the *RPL21A* pre-mRNAs, *MUD2* deletion from the *trf4*Δ background (∼1.4-fold) could led to a more severe *RPL21A* pre-mRNA accumulation phenotype (∼1.9-fold) ([Figure 7](#gkt888-F7){ref-type="fig"}B), which further demonstrated the negative genetic interaction between the two genes. In addition, we also uncovered the negative genetic interaction between *TRF4* and the U2 snRNP gene *MSL1*. Double knockout yeast strains lacking both *TRF4* and *MSL1* showed a much more severe growth defect than either of the corresponding single knockout strains ([Figure 7](#gkt888-F7){ref-type="fig"}C). Although *MSL1* deletion from wild-type cells already resulted in a significant increase (∼1.5-fold compared to wild-type) in the level of *RPL21A* pre-mRNAs, the effect of its deletion was moderately greater (∼2.7-fold compared to wild-type; ∼1.9-fold compared to *trf4*Δ) in the *trf4*Δ background ([Figure 7](#gkt888-F7){ref-type="fig"}D), suggesting that negative genetic interaction also exists between *TRF4* and *MSL1*. The negative genetic interactions between *TRF4* and splicing factor genes implied a linkage between the TRAMP complex and the pre-mRNA splicing machinery. Figure 7.Trf4p shows genetic and physical interactions with splicing factors. (**A** and **C**) Ten-fold serial dilutions of yeast cultures with the indicated genotypes were spotted onto YPD agar plates and then incubated at 30°C for 2 days. (**B** and **D**) RT-PCR analysis of the unspliced (Un) and spliced (S) *RPL21A* transcripts in the indicated yeast strains. The numbers shown at the bottom represent the ratio of unspliced to spliced transcripts relative to that of the wild-type cells. (**E**) Yeast strains expressing Trf4p-myc together with or without a TAP-tagged protein, as indicated, were grown in YPD medium to log-phase and then subjected to immunoprecipitation using IgG agarose beads. Both the input (1% of the amount used for immunoprecipitation) and immunoprecipitated proteins (10% of the eluted proteins for Air2p-TAP and 50% for others) were subsequently analysed by western blotting.

Trf4p physically interacts with splicing factors
------------------------------------------------

Cotranscriptional recruitment of TRAMP complex is enriched at intronic regions ([Figures 2](#gkt888-F2){ref-type="fig"} and [3](#gkt888-F3){ref-type="fig"}) with recruitment patterns similar to factors involved in the early stage of spliceosome assembly ([@gkt888-B40]). However, several previous large-scale pull-down of TRAMP components failed to identify any physically interacting splicing factors ([@gkt888-B3]). We hypothesized that the absence of any detectable physical interactions between TRAMP components and splicing factors in these experiments was due to their relatively weak and transient interactions inside cells. To overcome this difficulty, we adapted a previously used coimmunoprecipitation protocol to capture transient protein--protein interactions by formaldehyde crosslinking ([@gkt888-B55]) for examining the physical interactions between Trf4p and the early splicing factors Prp42p (U1-snRNP component), Msl5p (branch-point binding protein), and Lea1p (U2-snRNP component). The possible physical interactions between Trf4p and the late splicing factors Prp43p (required for spliceosome disassembly after splicing) and Prp16p (required for the second catalytic step of splicing) were also analysed.

We constructed yeast strains capable of expressing myc-tagged Trf4p together with or without a TAP-tagged splicing factor. Trf4p-myc could be detected in the immunoprecipitate when any one of the five tested splicing factors ([Figure 7](#gkt888-F7){ref-type="fig"}E, lanes 5--9) was pulled-down, while no Trf4p-myc could be observed in the negative controls when either the eIF3 subunit Tif32p-TAP ([Figure 7](#gkt888-F7){ref-type="fig"}E, lane 3) or no TAP-tagged proteins ([Figure 7](#gkt888-F7){ref-type="fig"}E, lane 1) was immunoprecipitated. This result demonstrated that at least transient physical interactions exist between Trf4p and these splicing factors, suggesting the possibility that TRAMP may enhance pre-mRNA splicing by facilitating splicing factor recruitment.

Trf4p contributes to the cotranscriptional recruitment of Msl5p to intronic regions
-----------------------------------------------------------------------------------

The branch-point binding protein Msl5p was the strongest Trf4p-interacting early splicing factor in our coimmunoprecipitation experiment ([Figure 7](#gkt888-F7){ref-type="fig"}E). Therefore, we examined whether Msl5p-TAP recruitment is affected in *trf4*Δ cells by ChIP. The cotranscriptional recruitment of Msl5p-TAP to both *RPL18B* (regions A and B) and *ECM33* (region B) ([Figure 8](#gkt888-F8){ref-type="fig"}A) was significantly reduced in *trf4*Δ cells as compared to *TRF4*-complemented cells ([Figure 8](#gkt888-F8){ref-type="fig"}B), even despite a generally higher Rpb3p recruitment level in *trf4*Δ ([Figure 8](#gkt888-F8){ref-type="fig"}C). As a result, the Msl5p-TAP to Rpb3p occupancy ratios at *RPL18B* (regions A and B) and *ECM33* (regions A and B) increased substantially after the *TRF4* gene was introduced into the corresponding *trf4*Δ cells ([Figure 8](#gkt888-F8){ref-type="fig"}D). Similar results could also be obtained by the analysis of *RPL18B* (region A) intronic chromatin fragments ([Figure 8](#gkt888-F8){ref-type="fig"}A) using PCR with radiolabeling ([Figure 8](#gkt888-F8){ref-type="fig"}E and F). All observed differences in Msl5p-TAP recruitment were not due to changes in protein expression levels, as Msl5p-TAP showed equal expression in both the presence and absence of Trf4p ([Figure 8](#gkt888-F8){ref-type="fig"}G). Our results indicated that Trf4p can facilitate the cotranscriptional recruitment of Msl5p, and that impaired Msl5p recruitment at least partially contributes to the splicing defects observed in yeast strains with deletion of TRAMP complex components. Figure 8.Trf4p is required for optimal recruitment of the splicing factor Msl5p. (**A**) Schematic diagram of the intron-containing genes *RPL18B* and *ECM33*, showing regions subjected to ChIP analysis. (**B--D**) *trf4*Δ strain expressing TAP-tagged Msl5p was transformed with either empty vector or a *TRF4*-containing plasmid, and then subjected to ChIP analysis with cells grown in SC medium lacking leucine. The purified input and immunoprecipitated chromatin fragments were analysed by qPCR, yielding the Msl5p-TAP occupancies, Rpb3p occupancies and Msl5p-TAP to Rpb3p occupancy ratios plotted in (B), (C) and (D), respectively. (**E--F**) The *RPL18B* intron (region A) fragments, together with the non-coding region control *ChrV*, were analysed by radioactive PCR in the presence of (^33^P)-dCTP. Representative results and the calculated Msl5p-TAP to Rpb3p occupancy ratios are shown in (E) and (F), respectively. Student's *t*-test was applied to confirm that the indicated differences in Msl5p-TAP occupancies or Msl5p-TAP to Rpb3p occupancy ratios between *trf4*Δ cells transformed with empty vector and those carrying a *TRF4*-containing plasmid were statistically significant (\* represents *P* \< 0.05 and \*\* represents *P* \< 0.01). All results shown represent the average from at least three independent cultures, with error bars showing the standard errors of the mean. (**G**) Whole-cell extracts from cells with the same genotypes as those used for the ChIP analysis in (B--F) were subjected to western blot analysis using antibodies against the TAP tag of Msl5p-TAP and the loading control Pgk1p.

DISCUSSION
==========

In this work, we demonstrated that both the TRAMP complex and the nuclear exosome component Rrp6p are cotranscriptionally recruited to intron-containing transcripts, particularly to intronic regions ([Figures 2](#gkt888-F2){ref-type="fig"} and [3](#gkt888-F3){ref-type="fig"}), and uncovered a novel role of TRAMP in promoting optimal pre-mRNA splicing efficiency ([Figures 1](#gkt888-F1){ref-type="fig"}, [4](#gkt888-F4){ref-type="fig"} and [5](#gkt888-F5){ref-type="fig"}). Since TRAMP is also cotranscriptionally recruited to the intronless *lacZ* reporter transcript ([Figure 2](#gkt888-F2){ref-type="fig"}), and it can facilitate recruitment of the splicing factor Msl5p to intronic sequences ([Figure 8](#gkt888-F8){ref-type="fig"}), it is very likely that TRAMP is recruited to intron-containing transcripts before or during splicing. Based on our findings, we propose a revised model for the coupling between nuclear RNA quality control and pre-mRNA splicing ([Figure 9](#gkt888-F9){ref-type="fig"}). First, TRAMP, together with the nuclear exosome, are recruited to the nascent pre-mRNAs, particularly to the introns, in a cotranscriptional manner. After that, TRAMP stimulates splicing of the pre-mRNAs by enhancing Msl5p (and possibly other splicing factors) recruitment. After splicing, the spliced-out introns will remain associated with TRAMP and then degraded by the nuclear exosome to prevent their accumulation in the cells. The cotranscriptional recruitment of TRAMP and the nuclear exosome to pre-mRNAs may also be important to commit splicing-defective pre-mRNAs to rapid degradation if a functional spliceosome fails to be assembled. Figure 9.A working model for the coupling between nuclear RNA quality control and pre-mRNA splicing. (Left) During transcription of an intron-containing gene by RNA polymerase II, TRAMP, together with the nuclear exosome, is recruited to the nascent pre-mRNA, especially to the intronic region. (Middle) TRAMP then stimulates splicing of the pre-mRNA by enhancing Msl5p recruitment. (Right) After splicing, TRAMP still remains associated with the spliced-out intron, which is then degraded by the nuclear exosome to prevent its accumulation. The cotranscriptional recruitment of TRAMP and the nuclear exosome may also function to recognize and degrade the splicing-defective pre-mRNA produced as a result of splicing errors.

We envision that the stimulatory role of TRAMP in pre-mRNA splicing may have important functional significance to its primary role in spliced-out intron recognition. Efficient degradation of spliced-out introns probably requires the binding of TRAMP to intronic sequences before or during splicing, that is, before the introns are spliced-out. Thus, the facilitation of splicing by TRAMP may serve as a safety mechanism to ensure the timely (before or during splicing) recruitment of TRAMP to intronic sequences. As a result, pre-mRNA splicing only proceeds at the optimal efficiency after the binding of TRAMP. This mechanism may serve to prevent introns that are not yet bound by TRAMP from being spliced-out.

Recently, it has been suggested that negative splicing regulation triggers the degradation of pre-mRNAs by the nuclear exosome, providing another layer of expression control of intron-containing genes ([@gkt888-B75]). Since TRAMP is probably involved in both pre-mRNA degradation (by being a cofactor of the nuclear exosome) ([@gkt888-B36]) and splicing (this study), it is likely that this kind of gene regulatory mechanism may also require TRAMP. It is potentially interesting to examine how TRAMP may regulate the expression of intron-containing genes through its roles in pre-mRNA degradation and/or splicing.

It remains to be determined how the nuclear RNA quality control system distinguishes introns from the surrounding exonic sequences. It has been proposed that the kinetic competition between proper formation of a functional RNP and commitment to degradation by the RNA quality control system determines the fate of nascent RNA transcripts ([@gkt888-B1],[@gkt888-B2],[@gkt888-B6]). The enrichment of TRAMP and nuclear exosome at introns may also act by a similar kinetics-based mechanism. As splicing may delay the assembly of an export-competent RNP, an extended time interval is probably available for further recruitment of TRAMP and the nuclear exosome to introns. It would be of great interest to experimentally delineate the exact mechanism underlying the specific enrichment of their recruitment at intronic sequences.

The human homologs of both the nuclear exosome and TRAMP in budding yeast have already been identified ([@gkt888-B76],[@gkt888-B77]). Recently, the human homologs of yeast Trf4p, Mtr4p and Rrp6p, have been shown to interact with U4/U6-U5 tri-snRNP components, suggesting that association between the nuclear RNA quality control machinery and splicing complexes may also occur in human cells ([@gkt888-B46]). Given that a higher frequency of introns can be found in the human genome, an efficient nuclear RNA quality control system is particularly important for the rapid degradation of an increased amount of spliced-out introns. It is tempting to determine how the recognition and degradation of spliced-out introns is coupled to the nuclear RNA quality control pathway in human cells, and this remains a major goal for future research.
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